IN the course of a clinical trial of the hypotensive drug guanethidine, it was observed that a proportion of treated patients developed edema or an unexplained gain in weight, thought to be a result of fluid retention.'
Emslie-Smith, and Milne2 reported a further series, noting fluid retention yet being unable to correlate it with any diminution in the urinary excretion of sodium or water in the two patients they studied by balance technics. The association of fluid retention and temporary loss of blood pressure control, both easily reversed by diuretic drugs, was later reported in more detail. 3 A review of the literature on hypotensive drug treatment reveals many reports of similar fluid retention occurring with a range of different drugs. Perera,4 5 MacArthur, 6 Melick and McGregor,7 and Winer8 reported and investigated this side effect during treatment with reserpine while Fraser and Lowe9 and Ronnov-Jessen'0' 11 recorded its production by ganglion-blocking drugs. More recently, alphamethyl dopa has also been shown to have fluid-retaining properties.12' 13 It has been variously assumed that progressive impairment of renal function resulting from postural hypotension, venous pooling in the extremities, or reduction in cardiac output was responsible, either singly or in combination, for this inconvenient and occasionally dangerous side effect. R0nnov-Jessen'0 emphasized the renal factors when he stated: "it is possible that the reduction in the blood pressure prevents an affected kid- From To provide a more objective criterion for the diagnosis of renal impairment, the pretreatment blood urea levels of the 134 patients were examined.
In a routine clinic it was not possible to perform more refined tests of renal function in every patient and those with a pretreatment blood urea exceeding 70 mg./100 ml. were not given as potent a hypotensive agent as guanethidine. The Figure 2 shows the average weight changes for these patients at 3, 6, 9, and 12 months. Though the deviations from constant weight are small, the trend suggests that treatment with guanethidine is associated with weight gain (which could be the result of fluid retention) in most or all patients rather than in a selected group possessing distinguishing features. The importance and extensive prevalence of that form of disease, which, after it has continued for some time, is attended by the peculiar changes in the structure of the kidney, now pretty generally known by the names of "mottling," "white degeneration," "contraction," or "granulation," impresses itself every year more and more deeply on my mind; and whether I turn to the wards of the hospital, or reflect on the experience of private practice, I find, on every side, such examples of its fatal progress and unrelenting ravages, as induce me to consider it amongst the most frequent, as well as the most certain causes of death in some classes of the community, while it is of common occurrence in all; and I believe I speak within bounds, when I state, that not less than five hundred die of it annually in London alone. It is, indeed, an humiliating confession, that, although much attention has been directed to this disease for nearly ten years, and during that time there has probably been no period in which at least twenty cases might not have been pointed out in each of the large hospitals of the metropolisand there is reason to believe that double that number may, at this moment, and at all times, be found in the wards of Guy's Hospital-yet little or nothing has been done towards devising a method of permanent relief, when the disease has been confirmed; and no fixed plan has been laid down, as affording a tolerable certainty of cure in the more recent cases. 
